BMD

Manufacturer
Phibro Animal Health
Effective date
2026-02-24
Label type
OTC TYPE A MEDICATED ARTICLE ANIMAL DRUG LABEL
Version
8
Source
full-release
Hydrated at
2026-06-01 02:46:30

Label at a glance#

ProductBMD
Active ingredientBACITRACIN METHYLENEDISALICYLATE
Label structure10 sections

Dosage and administration

Prepare an intermediate premix containing 5 grams per pound by mixing 1.0 lb of BMD 50 with 9.0 lbs of a feed ingredient(s) or a portion of the non-medicated feed. Then add 0.8 to 50 lbs of intermediate premix per ton of finished feed.

Label contents#

Full prescribing information#

SPL UNCLASSIFIED SECTION

BMD® 50

Bacitracin methylenedisalicylate
Type A Medicated Article
Antibacterial

For supplementing rations of swine, chickens, turkeys, pheasants, quail and feedlot beef cattle

Active drug ingredient

OTC - ACTIVE INGREDIENT SECTION

Each pound contains feed grade bacitracin methylenedisalicylate equivalent to 50 grams bacitracin (Master Standard).

Composition

SPL UNCLASSIFIED SECTION

A dried precipitated fermentation product obtained by culturing B. licheniformis Tracy on media adapted for microbiological production of bacitracin; calcium carbonate.

OTC - PURPOSE SECTION

For manufacturing medicated poultry and livestock feeds only

Mixing directions

DOSAGE & ADMINISTRATION SECTION

Prepare an intermediate premix containing 5 grams per pound by mixing 1.0 lb of BMD 50 with 9.0 lbs of a feed ingredient(s) or a portion of the non-medicated feed. Then add 0.8 to 50 lbs of intermediate premix per ton of finished feed.

VETERINARY INDICATIONS SECTION

Species Grams bacitracin
per ton of feed
Indications for use
Broiler and replacement chickens 4 - 50 For increased rate of weight gain and improved feed efficiency.
 50 As an aid in prevention of necrotic enteritis caused or complicated by Clostridium spp. or other organisms susceptible to bacitracin methylenedisalicylate.
 100 - 200

 As an aid in control of necrotic enteritis caused or complicated by Clostridium spp. or other organisms susceptible to bacitracin methylenedisalicylate.

CAUTION: To control a necrotic enteritis outbreak, start medication at the first clinical signs of disease. The dosage range permitted provides for different levels based on severity of the infection. Consult a poultry diagnostic laboratory or pathologist to determine the diagnosis and advice regarding the optimal level of drug. Administer continuously for 5 - 7 days or as long as clinical signs persist, and then reduce medication to prevention level (50 g/ton).
Laying hens 10 - 25 For increased egg production and improved feed efficiency during the first seven months of production.
Growing turkeys 4 - 50 For increased rate of weight gain and improved feed efficiency.
 200 As an aid in control of transmissible enteritis in growing turkeys complicated by organisms susceptible to bacitracin methylenedisalicylate.
Pheasants 4 - 50 For increased rate of weight gain and improved feed efficiency.
Quail 5 - 20 For increased rate of weight gain and improved feed efficiency in quail not over 5 weeks of age.
 200 For prevention of ulcerative enteritis in growing quail due to Clostridium colinum susceptible to bacitracin methylenedisalicylate. Feed continuously as the sole ration.
Growing/finishing swine 10 - 30 For increased rate of weight gain and improved feed efficiency.
 250 For control of swine dysentery (bloody scours) associated with Brachyspira hyodysenteriae in pigs up to 250 lbs body weight. Feed 250 grams per ton of complete feed on premises with a history of swine dysentery, but where signs of the disease have not yet occurred or following an approved treatment of the disease condition.
 The 250 g/ton level will provide 5 to 7 mg/lb in swine weighing 40 to 250 lbs.
CAUTION: Diagnosis should be confirmed by a veterinarian when results are not satisfactory. Feed containing an approved level of bacitracin methylenedisalicylate should be the sole ration.
Pregnant sows 250 For control of clostridial enteritis caused by C. perfringens in suckling piglets when fed to sows from 14 days before through 21 days after farrowing on premises with a history of clostridial scours.
CAUTION: Diagnosis should be confirmed by a veterinarian when results are not satisfactory. Feed containing an approved level of bacitracin methylenedisalicylate should be the sole ration.
Feedlot beef cattle mg/head/day
 70
(continuously)
 For reduction in the number of liver condemnations due to abscesses in feedlot beef cattle.
 250
(5 days in 30)
 For reduction in the number of liver condemnations due to abscesses in feedlot beef cattle.

SPL UNCLASSIFIED SECTION

Note: Where minimum levels are shown, increase the antibiotic concentration within approved range when necessary to fit the feeding program, and to insure adequate levels of antibiotic in the complete ration.

Restricted Drug (California) - Use only as directed.
Not for human use.
For Use in Dry Feeds Only.
Not for Use in Liquid Medicated Feeds.

Store below 25°C (77°F), excursions permitted to 37°C (99°F).

Approved by FDA under NADA # 046-592

WITHDRAWAL PERIODS

SPL UNCLASSIFIED SECTION

No withdrawal period is required when used according to labeling.

SPL UNCLASSIFIED SECTION

Questions/Comments? For technical assistance or to obtain a Safety Data Sheet(s), contact Phibro Animal
Health at 888-403-0074 or www.pahc.com. To report side effects, contact Phibro Animal Health Corporation at
1-888-475-7355. For additional information about reporting side effects for animal drugs, contact FDA at
1-888-FDA-VETS or www.fda.gov/reportanimalae


Phibro, Phibro logo and BMD are trademarks owned by or licensed to Phibro Animal Health Corporation or its affiliates.


Distributed by:
Phibro Animal Health Corporation
Teaneck, NJ 07666

Net Wt 50 LB (22.68 kg)
176-9016-02Take Time StatementTake Time Statement

BMD 50

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

BMD 50 LabelBMD 50 LabelBMD 50 Label

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
2d352c73-a357-4193-a4de-dfdf9a2ac8e4Product name120150819

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
66104-1551-0BMD22.68 kg in 1 BAGGRANULE22.688

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 5 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
66104-155166104-1551-0

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 2 matching rows.

Source Document#

Source XML

Older Hydrated Versions#

Version, Effective date, Source table
VersionEffective dateSourceHydrated
72026-01-20monthly-update2026-06-03 17:49:28

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.